皮莫齐德和亚酸:一种新的多元件晶体实体,用于改善药物行为
Alessandra Buscarini1, Michael J Zaworotko2, Catiúcia R M O Matos2
1Department of Chemistry, Physical Chemistry Section & C.S.G.I. (Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase), University of Pavia, Via Taramelli 16, 27100 Pavia, Italy.
Molecules (Basel, Switzerland)
|December 17, 2024
概括
这项研究使用亚酸开发了一种新的晶体形式的皮莫齐德,显著改善了其溶解性和可湿性. 这种增强的皮莫齐德盐为治疗精神病提供了更快的吸收,无论胃病情如何.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 药物运输 药物运输 药物运输
背景情况:
- 皮莫齐德是一种抗精神病药物,具有较差的溶解性和生物可用性,限制了其治疗疗效.
- 开发新型配方对于克服像皮莫齐德这样溶解不良药物的局限性至关重要.
研究的目的:
- 通过与基酸共同结晶来增强皮莫齐德的药物特性.
- 描述新的晶体实体,并评估其在药物配方中的潜力.
主要方法:
- 液体辅助研磨被用来制备皮莫齐德-酸联合晶体.
- 进行了热分析,X射线衍射 (XRD),可溶性和可湿性研究.
- 准备了药片配方,并将其溶解概况与商业产品进行了比较.
主要成果:
- 一个新的晶体实体,被确定为0.66:0.33比的pimozide:adipic酸盐 ([PMZH]2[adipate]),已成功合成.
- 新的晶体形式表现出明显改善的溶解性和可湿性,与纯皮莫齐德相比.
- 用新的晶体形式配制的药片表现出快速溶解,在几分钟内实现药物可用性.
结论:
- 皮莫齐德-基酸盐是一种有前途的方法,可以提高难溶性皮莫齐德的生物可用性.
- 这种新型的晶体形式有可能改善精神分裂症和相关疾病患者的治疗结果.
- 改进的溶解特性确保了药物的快速吸收,最大限度地减少了由于胃状况的变化.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
282
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
282
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Factors Influencing Drug Absorption: Physicochemical Parameters
221
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
221
Factors Influencing Drug Absorption: Pharmaceutical Parameters
114
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
114
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305


